Nicholas Lydon
Impact in
- Hematology top 0.05%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Genetics top 0.05%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 15
- Chronic Myeloid Leukemia Treatments 15
- Genetics 13
- Chronic Lymphocytic Leukemia Research 12
- Co-authors
- Brian DrukerElisabeth BuchdungerJ. ZimmermannSayuri Ohno-JonesShu TamuraMoshe TalpazHagop M. KantarjianGerald M. Segal
- Journals
- Journal of Biological Chemistry (4 papers)Journal of Medicinal Chemistry (4 papers)Blood (3 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Biochemistry (1 paper)
- Partner nations
- SwitzerlandUnited StatesItaly
In The Last Decade
Nicholas Lydon
40 papers receiving 12.1k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Hematology 7.2k
- Genetics 4.8k
- Rheumatology 3.3k
- Gastroenterology 938
- Oncology 2.7k
Countries citing papers authored by Nicholas Lydon
This map shows the geographic impact of Nicholas Lydon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas Lydon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas Lydon more than expected).
Fields of papers citing papers by Nicholas Lydon
This network shows the impact of papers produced by Nicholas Lydon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas Lydon. The network helps show where Nicholas Lydon may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nicholas Lydon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 45 | |
| 2 | Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia: Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lympoblastic leukemia with the philadelphia chromosome | 2001 | 9 |
| 3 | Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia Hit paper breakdown → | 2001 | 3811 |
| 4 | Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia Hit paper breakdown → | 2000 | 645 |
| 5 | 1999 | 21 | |
| 6 | 1997 | 55 | |
| 7 | 1997 | 254 | |
| 8 | 1997 | 452 | |
| 9 | 1996 | 60 | |
| 10 | 1996 | 2 | |
| 11 | 1996 | 75 | |
| 12 | Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells Hit paper breakdown → | 1996 | 2773 |
| 13 | 1995 | 188 | |
| 14 | 1995 | 87 | |
| 15 | 1992 | 37 | |
| 16 | 1992 | 27 | |
| 17 | 1992 | 66 | |
| 18 | 1992 | 3 | |
| 19 | 1991 | 49 | |
| 20 | 1988 | 11 |
About Nicholas Lydon
Nicholas Lydon is a scholar working on Hematology, Genetics, Oncology, Organic Chemistry and Biotechnology, having authored 40 papers that have together received 12.6k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (15 papers), Chronic Lymphocytic Leukemia Research (12 papers), HER2/EGFR in Cancer Research (8 papers), PI3K/AKT/mTOR signaling in cancer (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Viral Infectious Diseases and Gene Expression in Insects (5 papers), Quinazolinone synthesis and applications (5 papers) and Synthesis and biological activity (4 papers). The work is most often cited by research in Hematology (7.2k citations), Genetics (4.8k citations), Rheumatology (3.3k citations), Gastroenterology (938 citations) and Oncology (2.7k citations). Nicholas Lydon has collaborated with scholars based in Switzerland, United States and Italy. Frequent co-authors include Brian Druker, Elisabeth Buchdunger, J. Zimmermann, Sayuri Ohno-Jones, Shu Tamura, Moshe Talpaz, Hagop M. Kantarjian, Gerald M. Segal, J. Ford and Renaud Capdeville. Their work appears in journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry, Blood, Bioorganic & Medicinal Chemistry Letters and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.